Faculty profile

Nicolas Bertrand

ResearcherUniversité Laval

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université Laval directory, so their courses may be missing. Find their university profile.

Nicolas Bertrand

Researcher

Health Sciences

Université Laval

Quebec City, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
23 publications in the last five years, latest in 2026.
Senior (last) author on 7 recent papers, a sign of leading a research group.
Principal investigator on 6 research grants (4 NSERC, 2 CIHR), most recently in 2023.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Lipid Nanoparticles Mechanism Of Adverse Reactions Mrna Vaccines Nanomedicines Poly(Ethylene Glycol)

Latest papers

Immobilized IgG-containing immune complexes require platelets to recruit neutrophils during inflammation.
The Journal of clinical investigation · 2026
Quantitative recovery of methoxy poly(ethylene glycol) and PEGylated nanosystems from complex biological matrices.
Nanoscale advances · 2026
Liposomal lipid nanoparticles containing dihydrosphingomyelin exhibit improved stability and extended hepatic and extrahepatic transfection.
Journal of controlled release : official journal of the Controlled Release Society · 2026

All 35 publications

Latest funding

Methods to study the long-term effects of nanoparticles in vivo
NSERC · 2023 · Principal investigator
$84,000
Causes and consequences of anti-PEG antibodies
CIHR · 2023 · Nominated PI
$887,400
Causes and consequences of anti-PEG antibodies
CIHR · 2022 · Nominated PI
$100,000

All 6 grants and awards

35 publications.

Immobilized IgG-containing immune complexes require platelets to recruit neutrophils during inflammation.

Bellio M, Allaeys I, Doré E, Vaillancourt M, Lévesque T, Monteil M, Vallières N, Desaulniers P, Bertrand N, Washington VA, Senis Y, Lacroix S, Fortin P, Belleannée C, Boilard E

The Journal of clinical investigation2026

DOI: 10.1172/jci195987 PMID: 41329518

Quantitative recovery of methoxy poly(ethylene glycol) and PEGylated nanosystems from complex biological matrices.

Coutu K, Dupré C, Gaudreault N, Ngabonziza Sangwa A, Bertrand N, Greschner AA, Gauthier MA

Nanoscale advances2026

DOI: 10.1039/d6na00559d PMID: 42516173

Liposomal lipid nanoparticles containing dihydrosphingomyelin exhibit improved stability and extended hepatic and extrahepatic transfection.

Liao S, Fox K, Birkenshaw A, Wadhwa A, Wang S, Bedard K, Gaudreault N, Rekve J, Cheng MHY, Bertrand N, Foster LJ, Harder KW, Ross CJD, Badea I, Blakney AK, Cullis PR

Journal of controlled release : official journal of the Controlled Release Society2026

DOI: 10.1016/j.jconrel.2026.115098 PMID: 42285307

Direct Quantification of PEGylation for Intact Bioconjugates and Nanoparticles by the Colorimetric Barium/Iodide Assay

Coutu K, Sangwa AN, Gaudreault N, Tayebi SS, Hoare T, Mhaskar P, Bertrand N, Greschner AA, Gauthier MA

Biomacromolecules20253 citations

DOI: 10.1021/acs.biomac.5c00274

Effect of kidney disease and vascular calcification on the circulation and distribution of tetracycline-functionalized polymer nanoparticles.

Maio VDP, Ung RV, Greffard K, Gaudreault N, Picard S, Mac-Way F, Bertrand N

Nanoscale2025Senior author

DOI: 10.1039/d5nr01158b PMID: 40557778

Glycerol-Based Polymer to Improve the Cellular Uptake of Liposomes.

Roussel S, Carrera Fragoso L, Grenier P, Bruxelles Q, Chénard V, Marcoux S, Greffard K, Fortin S, Vallières L, Bertrand N

Biomacromolecules2025Senior author

DOI: 10.1021/acs.biomac.4c01110 PMID: 40258592

A Physicochemical Stability Study of Pembrolizumab Vial Leftovers: Let Us Stop Pouring Good Money Down the Drain.

Porlier A, Gagnon PY, Chénard V, Veillette M, Bertrand N, Duchaine C, Simard C, Drolet B

Pharmacy (Basel, Switzerland)2025

DOI: 10.3390/pharmacy13010022 PMID: 39998020

Secretory phospholipase A2-IIA targets bacterial extracellular vesicles to modulate immune signaling.

Doré E, Bérubé È, Greffard K, Morozumi S, Chénard V, Lemaire G, Allaeys I, Lévesque T, Rudkowska I, Brisson AR, Lambeau G, Bertrand N, Boissinot M, Arita M, Bilodeau JF, Isabel S, Boilard E

Communications biology2025

DOI: 10.1038/s42003-025-09025-4 PMID: 41272129

Targeting Cytokines: Evaluating the Potential of Mesenchymal Stem Cell Derived Extracellular Vesicles in the Management of COVID-19.

Schultz IC, Dos Santos Pereira Andrade AC, Dubuc I, Laroche A, Allaeys I, Doré E, Bertrand N, Vallières L, Fradette J, Flamand L, Wink MR, Boilard E

Stem cell reviews and reports2025

DOI: 10.1007/s12015-024-10794-4 PMID: 39340739

Encapsulation of conjugated linoleic acid and ruminant trans fatty acids to study the prevention of metabolic syndrome-a review.

Mohammadi F, Dikpati A, Bertrand N, Rudkowska I

Nutrition reviews2024

DOI: 10.1093/nutrit/nuad047 PMID: 37221703

Something wrong or missing on this profile? Suggest a correction

Nicolas Bertrand

Research

Latest papers

Latest funding

Immobilized IgG-containing immune complexes require platelets to recruit neutrophils during inflammation.

Quantitative recovery of methoxy poly(ethylene glycol) and PEGylated nanosystems from complex biological matrices.

Liposomal lipid nanoparticles containing dihydrosphingomyelin exhibit improved stability and extended hepatic and extrahepatic transfection.

Direct Quantification of PEGylation for Intact Bioconjugates and Nanoparticles by the Colorimetric Barium/Iodide Assay

Effect of kidney disease and vascular calcification on the circulation and distribution of tetracycline-functionalized polymer nanoparticles.

Glycerol-Based Polymer to Improve the Cellular Uptake of Liposomes.

A Physicochemical Stability Study of Pembrolizumab Vial Leftovers: Let Us Stop Pouring Good Money Down the Drain.

Secretory phospholipase A2-IIA targets bacterial extracellular vesicles to modulate immune signaling.

Targeting Cytokines: Evaluating the Potential of Mesenchymal Stem Cell Derived Extracellular Vesicles in the Management of COVID-19.

Encapsulation of conjugated linoleic acid and ruminant trans fatty acids to study the prevention of metabolic syndrome-a review.

Methods to study the long-term effects of nanoparticles in vivo

Causes and consequences of anti-PEG antibodies

Causes and consequences of anti-PEG antibodies

Analytical methods and analysis of in vivo toxicology of nanoparticles derived from the papaya-mosaic virus.

Engineering functional nanoparticles using libraries of polymers

Quaternized trimethyl chitosan nanoparticles to encapsulate peptides with poor oral bioavailability

Frequent collaborators

Iwona Rudkowska

Arnaud Droit

Eric Boilard

Chantale Simard

Steve Lacroix

Sandra Isabel

Donald Poirier

Paul Fortin

Fabrice Mac-Way

Manu Rangachari

Todd Hoare

Julie Fradette

Prashant Mhaskar

Jane Foster

Louis Flamand